GIANCARLO CORTEZ: Open Payments
NPI 1457035362 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 9 payments from 5 companies in 2025. Trend: 2023 $57 · 2024 $863 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $399 |
| Optinose US, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $18 |
| Biogen, Inc. | 1 | $17 |
Products named: JARDIANCE, Xhance, PREVNAR 20, Ozempic, SKYCLARYS.
Industry payments across NJ — which companies pay providers there.
